Griseofulvin
- Product NDC
- 64980-184
- 11-digit product format
- 649800184
- Labeler code
- 64980
- Product ID
- 64980-184_22d339ea-953f-4ef5-8f40-e3c2c7f41861
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Griseofulvin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Rising Pharmaceuticals, Inc
- Application
- ANDA202545
- Marketing category
- ANDA
- Marketing start
- 2012-11-15
- Marketing end
- 0000-00-00
- Substance
- GRISEOFULVIN
- Active strength
- 125 mg/1
- Pharmacologic classes
- Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 64980-184-01 | 64980018401 | 100 TABLET in 1 BOTTLE (64980-184-01) | 100 tablet | 2012-11-15 | 0000-00-00 | No | No | Current |
| 64980-184-03 | 64980018403 | 30 TABLET in 1 BOTTLE (64980-184-03) | 30 tablet | 2016-05-11 | 0000-00-00 | No | No | Current |